
Analysts Say Buy IonQ Stock, but Is Any Upside Really Left?
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Although full-scale quantum capabilities are still years away, the tech has already attracted significant investor interest and plenty of that interest has been pointed at IONQ's direction; to wit, the shares have generated returns of 519% over the past year.
This bullish sentiment is echoed by Cantor analyst Troy Jensen, who acknowledges that IonQ is still in the 'very early innings of commercializing its technology' but sees ample reason for the enthusiasm. Jensen believes the company could capture 20% of the quantum hardware, software, and services market by 2035, translating to $1.5 billion in sales within a decade.
Much of Jensen's confidence is rooted in IonQ's distinct approach to quantum computing. Unlike companies focused on superconducting or photonic systems, IonQ uses individual atomic ions as qubits, which enables greater stability and precision. Its vertically integrated technology stack spans everything from chip design and production to cloud access via platforms like Amazon Braket, Microsoft Azure, and IonQ Cloud.
'This gives IonQ end-to-end control of its technology and provides faster feedback loops for R&D. Its unique architecture also allows programmability and modular scalability, critical for achieving near-term commercial advantage. IonQ's ability to fabricate room-temperature systems also eliminates the need for expensive cryogenic infrastructure,' Jensen explained.
Meanwhile, IonQ is shifting from R&D to generating real revenue, with 'accelerating traction.' In April, it secured a $22 million system sale to EPB to create the first U.S. quantum computing and networking hub. Its Forte Enterprise system is already deployed in data centers across the U.S. and Europe. There are also Partnerships with Toyota Tsusho, Ansys, and General Dynamics, extending its presence into the automotive, simulation, and defense sectors. Furthermore, collaborations with DARPA, AFRL, and Abu Dhabi's Quantum Research Center 'demonstrate IonQ's credibility in national security and frontier research.'
IonQ's ambitions don't stop at quantum computing. The company is making major investments in quantum networking, which it views as a crucial second business vertical. Through acquisitions of companies like ID Quantique (completed) and Lightsynq Technologies (pending), IonQ has gained key intellectual property and expertise in quantum memory, repeaters, and photonic interconnects – all vital components for building a quantum internet and linking quantum computers across data centers. As a result, IonQ is now among the select few with 'commercial momentum in both quantum computing and quantum-safe networking.'
Crucially, IonQ has the financial strength to back these ambitions. By the end of Q1, it held nearly $700 million in cash and equivalents, bolstered by a recent $373 million equity offering.
'The capital enables the company to aggressively invest in product development, global expansion, and strategic M&A (i.e., Lightsynq & Oxford Ionics),' Jensen said.
Given this array of strengths – from technology and partnerships to financial firepower – it's no surprise that Jensen initiated coverage of IONQ with an Overweight (i.e., Buy) rating. What is surprising, however, is that his $45 price target implies only a modest 1% upside from current levels. (To watch Jensen's track record, click here)
All told, IonQ's rapid share appreciation has left analysts hustling to keep pace. The current $43.33 average price target points to a minor pullback, yet the Strong Buy consensus, based on 5 Buys and 1 Hold, underscores that most on Wall Street remain solidly bullish. It will be interesting to see whether the analysts raise price targets or downgrade their ratings over the coming months. (See IONQ stock forecast)
To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
IonQ (NYSE:IONQ) Announces Nearly US$1 Billion Follow-On Equity Offering
IonQ recently announced a significant follow-on equity offering amounting to approximately $1 billion in common stock and pre-funded warrants. This announcement coincided with the company's impressive quantum simulation breakthrough and its collaboration with AstraZeneca, AWS, and NVIDIA, all of which underscore its growth in quantum technologies and partnerships. These advancements likely contributed positively to IonQ's share price increase of 95% over the last quarter. Despite market fluctuations and tariff concerns, IonQ's accomplishments in quantum computing and strategic partnerships distinguished its performance from broader market trends. IonQ has 5 warning signs (and 1 which is a bit concerning) we think you should know about. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Over a period of three years, IonQ, Inc.'s shares delivered a very large total return of 775.54%, underscoring its substantial long-term growth. In the last year alone, IonQ outperformed both the US Market, which returned 13.7%, and the US Tech industry, with IonQ's annual return surpassing market benchmarks significantly. The recent collaborative efforts with AstraZeneca, AWS, and NVIDIA, coupled with the launch of quantum advancements, are crucial developments that could potentially bolster revenue growth, which is forecasted to increase by 40.2% annually. While earnings are expected to decline by an average of 2.2% per year over the next three years, these strategic alliances and innovations may influence future earnings positively. Despite the rapid share price increase of 95% over the last quarter, the shares currently trade at a slight discount to the consensus analyst price target of US$43.33. This price movement suggests optimism in IonQ's growth prospects, fueled by its groundbreaking technological advancements and strategic partnerships. Explore IonQ's analyst forecasts in our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IONQ. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@


Business Wire
3 hours ago
- Business Wire
SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing Standards
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. ('SunLink') (NYSE American: SSY) today announced that on Thursday, July 3, 2025, it received a deficiency letter (the 'Notice') from the NYSE American LLC ('NYSE American') stating that SunLink failed to hold an annual meeting of stockholders during SunLink's fiscal year ended June 30, 2025, as required by Section 704 of the NYSE American Company Guide (the 'Company Guide'). The Notice has no immediate impact on the listing of SunLink's common stock, which will continue to be listed and traded on the NYSE American during the applicable cure period, but will be assigned a '.BC' indicator by the NYSE to indicate that SunLink is below compliance. The '.BC' indicator will be removed at such time as SunLink is deemed compliant with the NYSE's continued listing standards. Likewise, the Notice has no expected impact on SunLink's planned merger with Regional Health Properties, Inc., a Georgia corporation ('Regional') which is being submitted to the shareholders of SunLink for approval at a special meeting of shareholders of SunLink, to be held in person at Hyatt House Hotel, 3595 Cumberland Blvd., Atlanta, Georgia 30339, at 10:00 a.m., Eastern time, on July 29, 2025 (the 'SunLink special meeting'). In the event the merger agreement is terminated for any reason, including any failure to obtain required shareholder approvals from the shareholders of SunLink and Regional, SunLink intends to hold its annual meeting no later than June 30, 2026, in order to regain compliance under the Company Guide. As amended, the merger agreement may be terminated by each of Regional and SunLink under certain circumstances, including if the merger is not consummated by 5:00 p.m., Eastern time, on August 11, 2025. NO OFFER OR SOLICITATION Communications in this press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any proxy vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the 'Securities Act'). ADDITIONAL INFORMATION The proposed merger will be submitted to both the SunLink and Regional shareholders for their consideration. In connection with the proposed merger, Regional has filed a Registration Statement on Form S-4 (the 'Registration Statement') with the U.S. Securities and Exchange Commission (the 'SEC') that includes a joint proxy statement/prospectus for SunLink and Regional and other relevant documents concerning the proposed merger. INVESTORS ARE URGED TO READ THE REGISTRATION STATEMENT AND THE CORRESPONDING JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE DOCUMENTS, AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. You are able to obtain a copy of the joint proxy statement/prospectus, as well as other filings containing information about SunLink and Regional, without charge, at the SEC's website ( or by accessing SunLink's website ( under the tab 'Investors' or by accessing Regional's website ( under the tab 'Investor Relations.' Copies of the joint proxy statement/prospectus have been mailed to the shareholders of SunLink and Regional who are, as of the respective record dates, entitled to vote on the merger, copies can also be obtained, without charge, by directing a request to Investor Relations, SunLink Health Systems, Inc., 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia, 30339, telephone 770-933-7004 or to Investor Relations, Regional Health Properties, Inc., 1050 Crown Pointe Parkway, Suite 720, Atlanta, Georgia, 30338, telephone 678-869-5116. SunLink and Regional and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of SunLink and Regional in connection with the proposed merger. Information about the directors and executive officers of SunLink is set forth in Part III of SunLink's Amendment No. 1 to Annual Report on Form 10-K/A for the fiscal year ended June 30, 2024, which information may be updated by SunLink from time to time in subsequent filings with the SEC. Information about the directors and executive officers of Regional is set forth in Part III of Regional's Annual Report on Form 10-K for the year ended December 31, 2024, which information may be updated by Regional from time to time in subsequent filings with the SEC. Additional information about the interests of those participants and other persons who may be deemed participants in the transaction may also be obtained by reading the joint proxy statement/prospectus relating to the proposed merger. Free copies of this document may be obtained as described above. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can often, but not always, be identified by the use of words like 'believe', 'continue', 'pattern', 'estimate', 'project', 'intend', 'anticipate', 'expect' and similar expressions or future or conditional verbs such as 'will', 'would', 'should', 'could', 'might', 'can', 'may', or similar expressions. These forward-looking statements include, but are not limited to, statements relating to the expected timing and benefits of the proposed merger between Regional and SunLink, including statements of Regional's goals, intentions and expectations; statements regarding Regional's business plan and growth strategies; and the ability of SunLink to meet the continued listing requirements of the NYSE American and to maintain the listing of securities thereon. These forward-looking statements are subject to significant risks, assumptions and uncertainties that may cause results to differ materially from those set forth in forward-looking statements, including, among other things: Litigation that may be filed against Regional, SunLink, the members of the Regional Board, the members of the SunLink Board or the officers of Regional or SunLink could result in substantial costs, and the possible unexpected or adverse outcomes of such litigation, any of which could adversely affect Regional's and SunLink's ability to complete the merger on a timely basis or at all; the ability to obtain the approvals of SunLink's or Regional's shareholders, and the ability to complete the merger on the expected timeframe; the ability of SunLink to meet the continued listing requirements or rules of the NYSE American LLC, the ability of Regional to meet the requirements of the OTCQB, and the ability of Regional to meet the initial listing requirements of the NYSE American after the merger, and, as applicable, the ability to maintain the listing or trading, as applicable, of securities thereon; the risk that the businesses of Regional and SunLink will not be integrated successfully, or such integration may be more difficult, time-consuming, or costly than expected; expected revenue synergies and cost savings from the merger may not be fully realized or realized within the expected time frame; revenues following the merger may be lower than expected; customer, vendor and employee relationships and business operations may be disrupted by the merger; possible changes in economic and business conditions; the impacts of epidemics, pandemics, or other infectious disease outbreaks; the existence or exacerbation of general geopolitical instability and uncertainty; possible changes in monetary and fiscal policies, and laws and regulations; competitive factors in the healthcare industry; Regional's dependence on the operating success of its operators; the amount of, and Regional's ability to service, its indebtedness; covenants in Regional's debt agreements that may restrict its ability to make investments, incur additional indebtedness, and refinance indebtedness on favorable terms; the effect of increasing healthcare regulation and enforcement on Regional's operators and the dependence of Regional's operators on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; the impact of litigation and rising insurance costs on the business of Regional's operators; the effect of Regional's operators declaring bankruptcy, becoming insolvent, or failing to pay rent as due; the ability of any of Regional's operators in bankruptcy to reject unexpired lease obligations and to impede its ability to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; Regional's ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; and other risks and factors identified in (i) SunLink's cautionary language included under the headings 'Forward-Looking Statements' and 'Risk Factors' in SunLink's Annual Report on Form 10-K for the year ended June 30, 2024, and other documents subsequently filed by SunLink with the SEC and (ii) Regional's cautionary language included under the headings 'Statement Regarding Forward-Looking Statements' and 'Risk Factors' in Regional's Annual Report on Form 10-K for the year ended December 31, 2024, and other documents subsequently filed by Regional with the SEC. Neither SunLink nor Regional undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters discussed in this press release. In addition, SunLink's and Regional's past results of operations do not necessarily indicate either of their anticipated future results, whether the merger is effectuated or not. SunLink Health Systems, Inc. is the parent company of subsidiaries that own and operate a pharmacy business and an information technology business in the Southeast. For additional information on SunLink Health Systems, Inc., please visit the Company's website. This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, without limitation, statements regarding the company's business strategy. These forward-looking statements are subject to certain risks, uncertainties, and other factors, which could cause actual results, performance, and achievements to differ materially from those anticipated. Certain of those risks, uncertainties and other factors are disclosed in more detail in the company's Annual Report on Form 10-K for the year ended June 30, 2024 and other filings with the Securities and Exchange Commission which can be located at
Yahoo
3 hours ago
- Yahoo
Avient To Hold Second Quarter 2025 Conference Call
CLEVELAND, July 7, 2025 /PRNewswire/ -- Avient Corporation (NYSE: AVNT), an innovator of materials solutions, intends to release its second quarter 2025 earnings before the market opens on Friday, August 1, 2025. The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Friday, August 1, 2025. The webcast can be viewed live at or by clicking on the webcast link here. Conference call participants in the question and answer session should pre-register using the link at or here, to receive the dial-in number and personal PIN. This information is required to access the conference call. The question and answer session will follow the company's presentation and prepared remarks. A recording of the webcast and the slide presentation will be available at immediately following the conference call and will be accessible for one year. About Avient Our purpose at Avient Corporation (NYSE: AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world. Our local touch and customer engagement, combined with our global presence, allows us to serve customers with agility. We harness the collective strength of more than 9,000 employees worldwide to collaborate and build on each other's ideas. In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends. Our expanding portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema®, the world's strongest fiber™. By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable. Visit to learn more. To access Avient's news library online, please visit View original content to download multimedia: SOURCE Avient Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data